United States · FDA National Drug Code directory
LOPREEZA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69238-1609_617a2d78-e850-4965-a23a-b0eacd0541a1
- Product NDC
- 69238-1609
- Form
- TABLET, FILM COATED
- Composition / generic term
- estradiol/norethindrone acetate
- Labeler
- Amneal Pharmaceuticals NY LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190107
- Source listing expiry
- 20261231
Source-listed ingredients
- ESTRADIOL — .5 mg/1
- NORETHINDRONE ACETATE — .1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (69238-1609-6) / 28 TABLET, FILM COATED in 1 BLISTER PACK · 69238-1609-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →